accountWASHINGTON -(Dow Jones)- A Food and Drug Administration panel Thursday backed a device made by a Johnson & Johnson (JNJ) unit to treat the common heart-rhythm disorder of atrial fibrillation in patients who've failed drug treatment. The device, known as...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to FDA Panel Backs Wider Approval Of J&J Heart Device
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account